Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term, Open-label Continuation Study to Assess the Safety of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With Hyperphosphataemia

NCT00358722 is registered in ClinicalTrials.gov with Ineos Healthcare Limited as lead sponsor.

NCT NCT00358722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00358722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term, Open-label Continuation Study to Assess the Safety of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With Hyperphosphataemia
Lead sponsor
Ineos Healthcare Limited
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2006
Completion date
June 30, 2008
Enrollment
44 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney failure